Walkthrough of a Pre-Approval Manufacturing Site Inspection (14of14) REdI 2018

Data Quality: Why Do We Care? (1of11) GCP Data Integrity

Pre-Approval Inspections: What to Expect When Being Inspected (15of15) REdI – May 29-30, 2019

Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies

FDA Drug Manufacturing Inspections - REdI 2020

Learn About ClinicalTrials.gov Modernization and How to Provide Input – Mar. 6, 2020

Understanding FDA Inspections and Data

FDA Drug Topic Webinar - Bad Ad Program

Putting the Pieces Together: REMS Logic Model in REMS Design, Implementation, and Evaluation

Advancing Smoking Cessation: FDA and NIH Priorities

77th Cellular, Tissue, and Gene Therapies Advisory Committee

National Native American Heritage Month: A Conversation with Dr. Casey Dorr

Conversations on Cancer - Pediatric Cancers: Navigating the Challenges Together

November 19, 2024 Joint Meeting of the DSaRM and the PDAC

Importing FDA-Regulated Products: Human Foods

FDA Tobacco Rulemaking 101 - How does FDA make rules about tobacco products?

Audio Transcript | The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball

MEDIA CALL: FDA’s Proposed Order on Phenylephrine – 11/7/2024

Antibiotics: Know When and How to Use Them

The Science of Generics: An FDA Researcher's Perspective | Researching FDA

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced ...